These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 24147084)
21. An Alternative Method for Screening Gastric Cancer Based on Serum Levels of CEA, CA19-9, and CA72-4. Yu J; Zheng W J Gastrointest Cancer; 2018 Mar; 49(1):57-62. PubMed ID: 28028765 [TBL] [Abstract][Full Text] [Related]
22. Significance of Serum Pepsinogens as a Biomarker for Gastric Cancer and Atrophic Gastritis Screening: A Systematic Review and Meta-Analysis. Huang YK; Yu JC; Kang WM; Ma ZQ; Ye X; Tian SB; Yan C PLoS One; 2015; 10(11):e0142080. PubMed ID: 26556485 [TBL] [Abstract][Full Text] [Related]
23. Serum miR-101-3p combined with pepsinogen contributes to the early diagnosis of gastric cancer. Zeng W; Zhang S; Yang L; Wei W; Gao J; Guo N; Wu F BMC Med Genet; 2020 Feb; 21(1):28. PubMed ID: 32041551 [TBL] [Abstract][Full Text] [Related]
24. Tumor markers for diagnosis, monitoring of recurrence and prognosis in patients with upper gastrointestinal tract cancer. Jing JX; Wang Y; Xu XQ; Sun T; Tian BG; Du LL; Zhao XW; Han CZ Asian Pac J Cancer Prev; 2014; 15(23):10267-72. PubMed ID: 25556459 [TBL] [Abstract][Full Text] [Related]
25. The role of serum and gastric juice levels of carcinoembryonic antigen, CA19.9 and CA72.4 in patients with gastric cancer. Tocchi A; Costa G; Lepre L; Liotta G; Mazzoni G; Cianetti A; Vannini P J Cancer Res Clin Oncol; 1998; 124(8):450-5. PubMed ID: 9750022 [TBL] [Abstract][Full Text] [Related]
26. Salivary glycopatterns as potential biomarkers for diagnosis of gastric cancer. Shu J; Yu H; Li X; Zhang D; Liu X; Du H; Zhang J; Yang Z; Xie H; Li Z Oncotarget; 2017 May; 8(22):35718-35727. PubMed ID: 28415698 [TBL] [Abstract][Full Text] [Related]
27. Differences and correlation of serum CEA, CA19-9 and CA72-4 in gastric cancer. Yu J; Zhang S; Zhao B Mol Clin Oncol; 2016 Mar; 4(3):441-449. PubMed ID: 26998301 [TBL] [Abstract][Full Text] [Related]
28. Combined use of AFP, CEA, CA125 and CAl9-9 improves the sensitivity for the diagnosis of gastric cancer. He CZ; Zhang KH; Li Q; Liu XH; Hong Y; Lv NH BMC Gastroenterol; 2013 May; 13():87. PubMed ID: 23672279 [TBL] [Abstract][Full Text] [Related]
29. A Liquid Biopsy Signature for the Early Detection of Gastric Cancer in Patients. Guo X; Peng Y; Song Q; Wei J; Wang X; Ru Y; Xu S; Cheng X; Li X; Wu D; Chen L; Wei B; Lv X; Ji G Gastroenterology; 2023 Aug; 165(2):402-413.e13. PubMed ID: 36894035 [TBL] [Abstract][Full Text] [Related]
30. Evaluation of Serum CEA, CA19-9, CA72-4, CA125 and Ferritin as Diagnostic Markers and Factors of Clinical Parameters for Colorectal Cancer. Gao Y; Wang J; Zhou Y; Sheng S; Qian SY; Huo X Sci Rep; 2018 Feb; 8(1):2732. PubMed ID: 29426902 [TBL] [Abstract][Full Text] [Related]
31. Comparison of serum CA72-4, CEA, TPA, CA19-9 and CA125 levels in gastric cancer patients and correlation with recurrence. Lai IR; Lee WJ; Huang MT; Lin HH Hepatogastroenterology; 2002; 49(46):1157-60. PubMed ID: 12143226 [TBL] [Abstract][Full Text] [Related]
32. Exosomal long noncoding RNA lnc-GNAQ-6:1 may serve as a diagnostic marker for gastric cancer. Li S; Zhang M; Zhang H; Hu K; Cai C; Wang J; Shi L; Ma P; Xu Y; Zheng P Clin Chim Acta; 2020 Feb; 501():252-257. PubMed ID: 31730812 [TBL] [Abstract][Full Text] [Related]
33. Serum OPN expression for identification of gastric cancer and atrophic gastritis and its influencing factors. Chen T; Sun L; He C; Gong Y; Xu Q; Yuan Y PLoS One; 2014; 9(12):e114005. PubMed ID: 25479069 [TBL] [Abstract][Full Text] [Related]
34. Clinical value of serum tumor markers CA19-9, CA125 and CA72-4 in the diagnosis of pancreatic carcinoma. Wang Z; Tian YP Mol Clin Oncol; 2014 Mar; 2(2):265-268. PubMed ID: 24649344 [TBL] [Abstract][Full Text] [Related]
35. Prognostic significance of preoperative serum CA125, CA19-9 and CEA in gastric carcinoma. Wang W; Chen XL; Zhao SY; Xu YH; Zhang WH; Liu K; Chen XZ; Yang K; Zhang B; Chen ZX; Chen JP; Zhou ZG; Hu JK Oncotarget; 2016 Jun; 7(23):35423-36. PubMed ID: 27097114 [TBL] [Abstract][Full Text] [Related]
36. [Establishment of risk evaluation model of peritoneal metastasis in gastric cancer and its predictive value]. Zhao J; Zhou R; Zhang Q; Shu P; Li H; Wang X; Shen Z; Liu F; Chen W; Qin J; Sun Y Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Jan; 20(1):47-52. PubMed ID: 28105619 [TBL] [Abstract][Full Text] [Related]
37. High throughput profiling of whole plasma N-glycans in type II diabetes mellitus patients and healthy individuals: A perspective from a Ghanaian population. Adua E; Memarian E; Russell A; Trbojević-Akmačić I; Gudelj I; Jurić J; Roberts P; Lauc G; Wang W Arch Biochem Biophys; 2019 Jan; 661():10-21. PubMed ID: 30365935 [TBL] [Abstract][Full Text] [Related]
38. Identification and validation of IgG N-glycosylation biomarkers of esophageal carcinoma. Pan H; Wu Z; Zhang H; Zhang J; Liu Y; Li Z; Feng W; Wang G; Liu Y; Zhao D; Zhang Z; Liu Y; Zhang Z; Liu X; Tao L; Luo Y; Wang X; Yang X; Zhang F; Li X; Guo X Front Immunol; 2023; 14():981861. PubMed ID: 36999031 [TBL] [Abstract][Full Text] [Related]
39. Increased Progastrin-Releasing Peptide Expression is Associated with Progression in Gastric Cancer Patients. Li L; Yin X; Meng H; Hu J; Yu Z; Xu J Yonsei Med J; 2020 Jan; 61(1):15-19. PubMed ID: 31887795 [TBL] [Abstract][Full Text] [Related]
40. [Clinical value of serum CEA, CA19-9, CA72-4 and CA242 in the diagnosis and prognosis of gastric cancer]. Zhu YB; Ge SH; Zhang LH; Wang XH; Xing XF; DU H; Hu Y; Li YA; Jia YN; Lin Y; Fan B; Ji JF Zhonghua Wei Chang Wai Ke Za Zhi; 2012 Feb; 15(2):161-4. PubMed ID: 22368025 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]